Market Cap 6.91B
Revenue (ttm) 1.61B
Net Income (ttm) 282.33M
EPS (ttm) N/A
PE Ratio 37.75
Forward PE 28.67
Profit Margin 17.53%
Debt to Equity Ratio 0.00
Volume 54,338,000
Avg Vol 70,077,055
Day's Range N/A - N/A
Shares Out 521.16M
Stochastic %K 17%
Beta 1.02
Analysts Sell
Price Target $17.12

Company Profile

UiPath, Inc. provides an automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. It offers the UiPath platform, an integrated enterprise software platform that enables AI agents, robots, people, and models to work together in coordinated workflows. The company's UiPath platform includes the UiPath Maestro process orchestration and process intelligence; UiPath agent bui...

Industry: Software - Infrastructure
Sector: Technology
Phone: 844 432 0455
Address:
One Vanderbilt Avenue, 60th Floor, New York, United States
Gunther77
Gunther77 Sep. 24 at 12:59 AM
$PATH i don't know why, but i keep buying it.
1 · Reply
Carlos7144
Carlos7144 Sep. 23 at 10:37 PM
$PATH https://www.reddit.com/r/UiPathBulls/s/1gOAcdvTGi
1 · Reply
Sam9961862
Sam9961862 Sep. 23 at 10:17 PM
$PATH https://www.prnewswire.com/news-releases/genzeon-named-uipath-2026-industry-impact-partner-of-the-year-for-healthcare-and-life-sciences-302888117.html
1 · Reply
UncleSteven
UncleSteven Sep. 23 at 9:55 PM
$PATH @DizPlinTrading Yeah man, agentic AI is still under the radar. It'll jump into view when the earnings reports show it. And we'll say, hey! I got in when it was only $13 or whatever! OG
1 · Reply
DizPlinTrading
DizPlinTrading Sep. 23 at 8:47 PM
$PATH Same story every time. Analysts want to “see the proof” before giving UiPath any credit for what they’re building. Meanwhile revenue grew 13%, ARR grew 12%, they’re GAAP profitable and full-year guidance has already been raised multiple times this year. Now they want proof that Maestro and agentic AI will accelerate growth before valuing it accordingly. Fair enough, but markets look forward. If you wait until the acceleration is obvious in the numbers, there’s every chance the share price has already reacted to it. That’s the whole point of investing before the proof becomes obvious! Know what you own folks 🤝
3 · Reply
Carl2233
Carl2233 Sep. 23 at 8:04 PM
$PATH Added a little in the 12's but its still very very bearish
0 · Reply
IdeletedRobinhood
IdeletedRobinhood Sep. 23 at 7:33 PM
$PATH Easy buy again at these levels Looks like a good hold into 2027 and 2028
0 · Reply
hopeium
hopeium Sep. 23 at 6:37 PM
$PATH I have a dream .. And it involves playing the sax!
0 · Reply
Theboss182
Theboss182 Sep. 23 at 5:59 PM
$PATH needs another -15% day or 3
0 · Reply
Entrepredoer
Entrepredoer Sep. 23 at 5:14 PM
$PATH 5000 at 13.03
0 · Reply
Latest News on PATH
UiPath announces enhancements to UiPath Test Cloud

2026-09-23T12:45:56.000Z - 13 hours ago

UiPath announces enhancements to UiPath Test Cloud


UiPath launches UiPath Cartographer

2026-09-23T12:45:45.000Z - 13 hours ago

UiPath launches UiPath Cartographer


UiPath announces enhancements to UiPath Platform

2026-09-23T12:45:39.000Z - 13 hours ago

UiPath announces enhancements to UiPath Platform


UiPath Enhances and Strengthens UiPath Platform™

Sep 23, 2026, 8:40 AM EDT - 13 hours ago

UiPath Enhances and Strengthens UiPath Platform™


UiPath sees long-term gross margin profile at 80% or more

2026-09-23T12:36:21.000Z - 13 hours ago

UiPath sees long-term gross margin profile at 80% or more


UiPath price target lowered to $14 from $17 at Truist

2026-09-23T12:35:57.000Z - 13 hours ago

UiPath price target lowered to $14 from $17 at Truist


UiPath Investor Day targets were ‘limited’, says TD Cowen

2026-09-23T12:25:28.000Z - 13 hours ago

UiPath Investor Day targets were ‘limited’, says TD Cowen


UiPath price target lowered to $15 from $17 at RBC Capital

2026-09-23T11:45:20.000Z - 14 hours ago

UiPath price target lowered to $15 from $17 at RBC Capital


UiPath price target lowered to $15 from $19 at UBS

2026-09-23T11:40:51.000Z - 14 hours ago

UiPath price target lowered to $15 from $19 at UBS


UiPath Transcript: Investor Day 2026

Sep 22, 2026, 2:30 PM EDT - 1 day ago

UiPath Transcript: Investor Day 2026


UiPath Slides: FY 2026

Sep 22, 2026, 2:30 PM EDT - 1 day ago

UiPath Slides: FY 2026


UiPath Transcript: Citi’s 2026 Global TMT Conference

Sep 8, 2026, 10:50 AM EDT - 15 days ago

UiPath Transcript: Citi’s 2026 Global TMT Conference


UiPath initiated with a Buy at Citi

2026-09-08T10:55:23.000Z - 15 days ago

UiPath initiated with a Buy at Citi


UiPath price target raised to $15 from $13 at BofA

2026-09-06T10:10:05.000Z - 17 days ago

UiPath price target raised to $15 from $13 at BofA


UiPath price target raised to $17 from $12 at Truist

2026-09-04T13:10:09.000Z - 19 days ago

UiPath price target raised to $17 from $12 at Truist


UiPath price target raised to $16 from $12 at DA Davidson

2026-09-04T12:50:19.000Z - 19 days ago

UiPath price target raised to $16 from $12 at DA Davidson


UiPath Earnings Call Transcript: Q2 2027

Sep 3, 2026, 5:00 PM EDT - 20 days ago

UiPath Earnings Call Transcript: Q2 2027


UiPath Earnings release: Q2 2027

Sep 3, 2026, 5:00 PM EDT - 20 days ago

UiPath Earnings release: Q2 2027


UiPath Slides: Q2 2027

Sep 3, 2026, 5:00 PM EDT - 20 days ago

UiPath Slides: Q2 2027


UiPath Quarterly report: Q2 2027

Sep 3, 2026, 5:00 PM EDT - 20 days ago

UiPath Quarterly report: Q2 2027


UiPath Reports Second Quarter Fiscal 2027 Financial Results

Sep 3, 2026, 4:10 PM EDT - 20 days ago

UiPath Reports Second Quarter Fiscal 2027 Financial Results


UiPath to Participate in the Citi 2026 Global TMT Conference

Sep 1, 2026, 4:10 PM EDT - 22 days ago

UiPath to Participate in the Citi 2026 Global TMT Conference


UiPath Announces Upcoming Investor Day

Aug 25, 2026, 8:30 AM EDT - 4 weeks ago

UiPath Announces Upcoming Investor Day


UiPath Transcript: AGM 2026

Jun 25, 2026, 11:00 AM EDT - 3 months ago

UiPath Transcript: AGM 2026


UiPath Earnings Call Transcript: Q1 2027

May 28, 2026, 5:00 PM EDT - 3 months ago

UiPath Earnings Call Transcript: Q1 2027


UiPath Earnings release: Q1 2027

May 28, 2026, 5:00 PM EDT - 3 months ago

UiPath Earnings release: Q1 2027


UiPath Slides: Q1 2027

May 28, 2026, 5:00 PM EDT - 3 months ago

UiPath Slides: Q1 2027


UiPath Quarterly report: Q1 2027

May 28, 2026, 5:00 PM EDT - 3 months ago

UiPath Quarterly report: Q1 2027


UiPath Reports First Quarter Fiscal 2027 Financial Results

May 28, 2026, 4:10 PM EDT - 3 months ago

UiPath Reports First Quarter Fiscal 2027 Financial Results


UiPath Proxy statement: Proxy filing

May 22, 2026, 8:00 AM EDT - 4 months ago

UiPath Proxy statement: Proxy filing


UiPath Proxy statement: Proxy filing

May 12, 2026, 8:00 AM EDT - 4 months ago

UiPath Proxy statement: Proxy filing


UiPath Proxy statement: Proxy filing

May 12, 2026, 8:00 AM EDT - 4 months ago

UiPath Proxy statement: Proxy filing


UiPath Transcript: Status update

Apr 6, 2026, 11:30 AM EDT - 5 months ago

UiPath Transcript: Status update


UiPath stock: why sell-off makes sense despite Q4 beat and buyback

Mar 12, 2026, 12:48 PM EDT - 6 months ago

UiPath stock: why sell-off makes sense despite Q4 beat and buyback


UiPath Earnings Call Transcript: Q4 2026

Mar 11, 2026, 5:00 PM EDT - 6 months ago

UiPath Earnings Call Transcript: Q4 2026


UiPath Annual report: Q4 2026

Mar 11, 2026, 5:00 PM EDT - 6 months ago

UiPath Annual report: Q4 2026


UiPath Earnings release: Q4 2026

Mar 11, 2026, 5:00 PM EDT - 6 months ago

UiPath Earnings release: Q4 2026


UiPath Slides: Q4 2026

Mar 11, 2026, 5:00 PM EDT - 6 months ago

UiPath Slides: Q4 2026


UiPath Annual report: Q4 2026

Mar 11, 2026, 5:00 PM EDT - 6 months ago

UiPath Annual report: Q4 2026


UiPath Profit, Revenue Rise as AI Adoption Spreads

Mar 11, 2026, 4:57 PM EDT - 6 months ago

UiPath Profit, Revenue Rise as AI Adoption Spreads


Gunther77
Gunther77 Sep. 24 at 12:59 AM
$PATH i don't know why, but i keep buying it.
1 · Reply
Carlos7144
Carlos7144 Sep. 23 at 10:37 PM
$PATH https://www.reddit.com/r/UiPathBulls/s/1gOAcdvTGi
1 · Reply
Sam9961862
Sam9961862 Sep. 23 at 10:17 PM
$PATH https://www.prnewswire.com/news-releases/genzeon-named-uipath-2026-industry-impact-partner-of-the-year-for-healthcare-and-life-sciences-302888117.html
1 · Reply
UncleSteven
UncleSteven Sep. 23 at 9:55 PM
$PATH @DizPlinTrading Yeah man, agentic AI is still under the radar. It'll jump into view when the earnings reports show it. And we'll say, hey! I got in when it was only $13 or whatever! OG
1 · Reply
DizPlinTrading
DizPlinTrading Sep. 23 at 8:47 PM
$PATH Same story every time. Analysts want to “see the proof” before giving UiPath any credit for what they’re building. Meanwhile revenue grew 13%, ARR grew 12%, they’re GAAP profitable and full-year guidance has already been raised multiple times this year. Now they want proof that Maestro and agentic AI will accelerate growth before valuing it accordingly. Fair enough, but markets look forward. If you wait until the acceleration is obvious in the numbers, there’s every chance the share price has already reacted to it. That’s the whole point of investing before the proof becomes obvious! Know what you own folks 🤝
3 · Reply
Carl2233
Carl2233 Sep. 23 at 8:04 PM
$PATH Added a little in the 12's but its still very very bearish
0 · Reply
IdeletedRobinhood
IdeletedRobinhood Sep. 23 at 7:33 PM
$PATH Easy buy again at these levels Looks like a good hold into 2027 and 2028
0 · Reply
hopeium
hopeium Sep. 23 at 6:37 PM
$PATH I have a dream .. And it involves playing the sax!
0 · Reply
Theboss182
Theboss182 Sep. 23 at 5:59 PM
$PATH needs another -15% day or 3
0 · Reply
Entrepredoer
Entrepredoer Sep. 23 at 5:14 PM
$PATH 5000 at 13.03
0 · Reply
StockWizard99
StockWizard99 Sep. 23 at 5:13 PM
$PATH Thanks for letting me get back in with an average of $12.88. The old bulls have sold and taken losses. The new young bulls are back in. I really thought this got away from me when this went over $20. Hehe.
0 · Reply
anachartanalyst
anachartanalyst Sep. 23 at 5:01 PM
$PATH https://anachart.com/wp-content/uploads/2026/09/1790182897_soc-img.jpg
0 · Reply
Baazigar123
Baazigar123 Sep. 23 at 4:54 PM
$PATH CRM CHAI
0 · Reply
StockWizard99
StockWizard99 Sep. 23 at 4:46 PM
$PATH Buying. 👹
0 · Reply
Biostockfollower
Biostockfollower Sep. 23 at 4:41 PM
$PATH stairs up, elevator down
0 · Reply
nothingbutUP
nothingbutUP Sep. 23 at 4:35 PM
$PATH I guess the investor day didn’t go so well, three price target cuts today from RBC, Truist, and UBS, I’m still long but geez….
1 · Reply
StockTradingBoy
StockTradingBoy Sep. 23 at 4:29 PM
$PATH Now it is getting attention...What a undervalued stock. This has great potential....You don't see a company with that much CASH sitting...and strong fundamentals...!!! Buy now or regret later kind of stock!
0 · Reply
kej32
kej32 Sep. 23 at 4:26 PM
$PATH Guess that was a morning shake out! Thank God I didn’t fall for it. Diabolical
1 · Reply
sam777777
sam777777 Sep. 23 at 4:24 PM
$PATH if it breaks 14 today then all retailers are missing something here.....
1 · Reply
Carlos7144
Carlos7144 Sep. 23 at 4:24 PM
$PATH 🟢
0 · Reply
Theboss182
Theboss182 Sep. 23 at 4:11 PM
$PATH Bring it below $10 🤑
0 · Reply
Dukeit
Dukeit Sep. 23 at 3:48 PM
$PATH I see shit headlines like this and ponder, how much longer will the bullshit persist. I’m not a paid member so the article is off limits for me.
0 · Reply